Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
08/2009
08/04/2009US7569591 topoisomerase inhibitors such as [5-(4-Cyclopropylcarbamoyl-imidazol-1-yl)-7-pyrimidin-2-yl-1H-benzoimidazol-2-yl]-carbamic acid ethyl ester, used for prophylaxis of bacterial infections in mammals
08/04/2009US7569589 (R)-N-{6-[1-(4-fluorophenyl)-2,2-dipyridin-3-ylethyl]pyridin-2-yl}methanesulfonamide; cardiac arrhythmias
08/04/2009US7569578 Heterocyclic anti-migraine agents
08/04/2009US7569573 Nucleobase substituted with a 2-hydroxy-4-oxobut-2-enoic acid or ester or a 1-hydroxy-3-oxopropenephosphonic acid or ester, e.g., Methyl 4-(1,3-dibenzyl-1,2,3,4-tetrahydro-2,4-dioxopyrimidin-5-yl)-2-hydroxy-4-oxobut-2-enoate
08/04/2009US7569568 1-[5-(5-tert-Butyl-2-methoxy-phenylcarbamoyl)-2-methyl-phenyl]-1H-1,2,3-triazole-4-carboxylic acid (2-morpholin-4-yl-ethyl)-amide; inflammation, chronic inflammatory disease
08/04/2009US7569561 For treating carcinoma chosen from cervical, breast, colon, head and neck, lung, pancreas, prostate, sarcomas, leukaemias, lymphomas, melanomas and gliomas
08/04/2009US7569516 5-substituted-1-arylpyrazole-3-carboxylic acid derivatives
08/04/2009CA2357014C Method of using (2-imidazolin-2-ylamino) quinoxalines in treating neural injury
07/2009
07/30/2009WO2009094442A2 5-fluoro pyrimidine derivatives as fungicides
07/30/2009WO2009093981A1 Triazine compounds as kinase inhibitors
07/30/2009WO2009093269A1 Novel heterocyclic compounds
07/30/2009WO2009092566A1 Substituted amino-benzimidazoles, medicaments comprising said compound, their use and their method of manufacture
07/30/2009WO2009092432A1 Beta-amino acid derivatives for treatment of diabetes
07/30/2009WO2009016526A3 Ethers of substituted 5-hydrixy-1h-indol-3-carboxylic acids, a pharmaceutical composition and a method for the production and use thereof
07/30/2009US20090192169 Bicyclic Benzimidazole Compounds and Their Use as Metabotropic Glutamate Receptor Potentiators
07/30/2009US20090192164 Treating agent of inflammatory bowel disease
07/30/2009US20090192157 Indole compounds and methods for treating visceral pain
07/30/2009US20090192138 compounds
07/30/2009US20090192134 Compounds
07/30/2009CA2712998A1 Beta-amino acid derivatives for treatment of diabetes
07/30/2009CA2712777A1 5-fluoro pyrimidine derivatives as fungicides
07/30/2009CA2712685A1 Novel heterocyclic compounds
07/30/2009CA2711713A1 Substituted amino-benzimidazoles, medicaments comprising said compound, their use and their method of manufacture
07/29/2009EP2083014A2 Inhibitors of interleukin-1ß converting enzyme
07/29/2009EP2083005A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
07/29/2009EP2082041A2 Novel genes related to glutaminyl cyclase
07/29/2009EP2081925A1 Benzoylpyrazoles, their use as as herbicides, and intermediates
07/29/2009EP2081912A1 Heterocyclic bridged biphenyls and their use in oleds
07/29/2009EP2081894A1 1h-indole-2-carboxylic acid derivatives useful as ppar modulators
07/29/2009EP2081893A2 Substituted indoles
07/29/2009EP2081890A1 Arylsulfonyl pyrrolidines as 5-ht6 inhibitors
07/29/2009EP2081572A1 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group
07/29/2009EP1926712B1 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
07/29/2009EP1753748B1 Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
07/29/2009EP1379566B1 Ion-sensitive cationic polymers and fibrous items using same
07/29/2009EP1363876B1 Glucocorticoid receptor modulators
07/29/2009CN101495472A Fungicide N-cycloalkyl-carboxamide derivatives
07/29/2009CN101495471A Novel indol-pyrrol derivatives for the treatment of proliferative and inflammatory diseases
07/29/2009CN101492416A Compounds effecting glucokinase
07/29/2009CN100519555C Novel indole derivative for alkylating specific base sequence of DNA, alkylating agent using the same and medicament
07/29/2009CN100519554C CCR5 antagonists for treating aids
07/29/2009CN100519553C Inhiitors of cyclin dependent kinases as anti-cancer agent
07/29/2009CN100519552C Pyrazole compounds
07/29/2009CN100519550C 2-oxo-indole compound having a functtion of inhibiting glycogen synthase kinase-3
07/29/2009CN100519539C N3 alkylated benzimidazole derivatives as MEK inhibitors
07/29/2009CN100519527C Inhibitors of histone deacetylase
07/29/2009CN100519526C Azabicyclo derivatives as muscarinic receptor antagonists
07/28/2009US7566790 Chemically reactive carbocyanine dyes incorporating an indolium ring moiety that is substituted at the 3-position by a reactive group or by a conjugated substance
07/28/2009US7566782 Process for the preparation of rosuvastatin
07/28/2009US7566755 Compound and composition produced by using such compound
07/28/2009US7566734 Imidazolyl derivatives
07/28/2009US7566732 5-(1H-benzimidazol-2-ylmethylene)-3-(4-fluorophenyl)-2-thioxo-1,3-thiazolidin-4-one; ubiquitin ligase (synthetase) inhibitors; inhibit ubiquitination of target proteins; poxviruses; herpesviruses; retroviruses; variola viruses; smallpox; hemorrhagic smallpox; HIV; vaccines; side effect reduction
07/28/2009US7566723 1-phenyl1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use
07/28/2009US7566718 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity
07/28/2009US7566712 Biaryl piperazinyl-pyridine analogues
07/28/2009US7566709 4-(3-(2-Fluorophenyl)-1-phenyl-1H-pyrazol-4-ylmethyl)morpholine; 5HT2A/5HT2C receptors; central nervous system; schizophrenia; antidepressants; dementia; Parkinson's disease; Azheimer's disease; Huntington's disease; Tourette's syndrome; anxiolytic agents; congnition activators; analgesics
07/28/2009CA2472008C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors
07/23/2009WO2009091832A1 Synthesis of pyrazoles
07/23/2009WO2009091831A1 Compound forms and uses thereof
07/23/2009WO2009091813A1 Compounds useful as alpha7 nicotinic acetylcholine receptor agonists
07/23/2009WO2009091759A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof
07/23/2009WO2009091618A1 Macrocyclic antiproliferation agents and methods of treatment
07/23/2009WO2009090548A2 3-azabicyclo [3.1.0] hexane derivatives as vanilloid receptor ligands
07/23/2009WO2009089851A1 Sulphoximine-substituted quinazoline derivatives as immunomodulators, their preparation and use as medicaments
07/23/2009WO2009063061A3 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
07/23/2009WO2009043747A3 N-heterocyclic biaryl carboxamides as ccr receptor antagonists
07/23/2009WO2009013348A3 Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions
07/23/2009WO2008096001A8 Hcv inhibiting macrocyclic phenylcarbamates
07/23/2009US20090186933 Indole, azaindole and related heterocyclic pyrrolidine derivatives
07/23/2009US20090186924 Substituted arylpyrazoles
07/23/2009US20090186913 Tetrahalogenated compounds useful as inhibitors of angiogenesis
07/23/2009US20090186911 (RS)-S-[3-({[6-Bromo-4-(isopropylamino)quinazolin-7-yl]oxy}methyl)phenyl] N-(ethoxycarbonyl)-S-ethylsulphoximide, used for the treatment of chronic inflammatory diseases, such as rheumatoid arthritis, Crohn's disease, asthma and multiple sclerosis
07/23/2009US20090186907 Pyrazinones As Cellular Proliferation Inhibitors
07/23/2009US20090186895 Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
07/23/2009US20090186877 Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
07/23/2009US20090186871 Tyrosine kinase inhibitors
07/23/2009US20090186867 Substituted Diketopiperazines As Oxytocin Antagonists
07/23/2009US20090184633 Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Appliance Using the Quinoxaline Derivative
07/23/2009CA2712367A1 Sulphoximine-substituted quinazoline derivatives as immunomodulators, their preparation and use as medicaments
07/23/2009CA2712262A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof
07/23/2009CA2710374A1 Fungicide hydroximoyl-tetrazole derivatives
07/22/2009EP2080756A2 Method for making losartan
07/22/2009EP2079736A1 Substituted triazoles useful as axl inhibitors
07/22/2009EP2079729A1 Compounds and compositions as protein kinase inhibitors
07/22/2009EP2079728A1 N-aryl pyrazole compounds for use against diabetes
07/22/2009EP2079715A1 Triazines and their use as inhibitors of metalloproteinases
07/22/2009EP2079703A1 Indazole derivatives useful as l-cpt1 inhibitors
07/22/2009EP2079701A1 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators
07/22/2009EP1928858B1 Solid salt forms of a pyrrole substituted 2-indolinone
07/22/2009EP1877052B1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
07/22/2009EP1778674A4 Novel benzimidazole compound
07/22/2009EP1745039A4 3-aryl-5,6-disubstituted pyridazines
07/22/2009EP1667996B1 Quinazoline derivatives
07/22/2009EP1646610B1 Tetrahydrocarbazole derivatives and their pharmaceutical use
07/22/2009EP1644337B1 Melanocortin-4 receptor binding compounds and methods of use thereof
07/22/2009EP1503988B1 Fredericamycin derivatives
07/22/2009EP1391456B1 2-iminoimidazole derivatives
07/22/2009CN101490041A 2-heterocycloamino-4-imidazolylpyrimidines as agents for the inhibition of cell proliferation
07/22/2009CN101490040A 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial
07/22/2009CN101490039A 1H-indol-6-yl-piperazin-1-yl-methanone-derivatives for use as H3 receptor modulators